ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/08/2025
Back to search
Official data from USPTO
QUIDELORTHO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUIDELORTHO
ST13
US500000097402981Class
1, 5, 9, 10, 42
Filing
97402981
Registration
7755067
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
10/09/2025
Trademark type
Word
Nice classes
1, 5, 9, 10, 42
Filing date
05/10/2022
Registration date
04/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2025
Last transaction
10/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/08/2023
First use in commerce
03/08/2023
Drawing code
4
Owner type
03
Owner location
SAN DIEGO, CA
Examiner
MCCARTHY,JOSEPH PATRICK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Q. C. (pessoa física)
Coronado Topco, Inc.
Representatives
Alexis Crawford Douglas K&L Gates LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagent test kits comprised of monoclonal antibodiesbuffersreagents for clinical or medical laboratoryscientific or research use; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor clinical laboratory use; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor clinical research use
Class 5
Chemicalbiochemical and biological preparations for medical use in cassette formfor use in measuringtesting and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposesfor use in connection with diagnostic test kits for the detection of a wide variety of diseasesconditionsdisorders; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor medical and clinical medical use; In vitro medical diagnostic test kits for clinicalprofessionalmedical and consumer use consisting primarily of medical diagnostic reagents together with test equipment in the nature of a medical testing device for monitoring medical conditionsmonitoring antibodiesdiagnosing viralinflammatory and infectious diseases and diagnosing and monitoring genetic disorders for medical use
Class 9
Clinical laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED)objective lensdigital camera charge-coupled device (CCD)motorized slide carrierdownloadable diagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; downloadable computer software for capturingorganizingreportingmanagement of medical information and data; Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens
Class 10
Devices in the nature of glass slidescupsbags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slidescupsbags and test components in the nature of medical testing devices sold as a kit for the collectionpreservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics windowa port for a reagent testan illuminating devicespecifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuringtesting and analyzing blood and other bodily fluids; In vitro medical diagnostic test kits for clinicalprofessionalmedical and consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease; Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens
Class 42
Providing online non-downloadable web-based software that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturingorganizingreportingremote management of medical information and data
Publications
History of USPTO decisions and trademark events.
47 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/17/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/17/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/23/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/23/2025
IUAF
USE AMENDMENT FILED
11/08/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/08/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2024
PUBO
PUBLISHED FOR OPPOSITION
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/26/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/25/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/25/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/26/2023
GNRT
NON-FINAL ACTION E-MAILED
07/26/2023
CNRT
NON-FINAL ACTION WRITTEN
07/26/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/24/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/13/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/12/2023
PBTQ
WITHDRAWN FROM PUB OTQR REQUEST
05/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2023
GNRT
NON-FINAL ACTION E-MAILED
03/06/2023
CNRT
NON-FINAL ACTION WRITTEN
03/06/2023
DOCK
ASSIGNED TO EXAMINER
02/28/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/16/2022
NWAP
NEW APPLICATION ENTERED
05/13/2022
Continuous trademark protection
Get notified about every new filing that threatens QUIDELORTHO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.